627 related articles for article (PubMed ID: 7992850)
1. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
[TBL] [Abstract][Full Text] [Related]
2. Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease.
Zubenko GS; Stiffler S; Stabler S; Kopp U; Hughes HB; Cohen BM; Moossy J
Am J Med Genet; 1994 Sep; 54(3):199-205. PubMed ID: 7810577
[TBL] [Abstract][Full Text] [Related]
3. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
4. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinct.
Strong C; Anderton BH; Perry RH; Perry EK; Ince PG; Lovestone S
Alzheimer Dis Assoc Disord; 1995; 9(4):218-22. PubMed ID: 8749611
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.
Polvikoski T; Sulkava R; Haltia M; Kainulainen K; Vuorio A; Verkkoniemi A; Niinistö L; Halonen P; Kontula K
N Engl J Med; 1995 Nov; 333(19):1242-7. PubMed ID: 7566000
[TBL] [Abstract][Full Text] [Related]
6. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB
Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.
Nitsch RM; Rebeck GW; Deng M; Richardson UI; Tennis M; Schenk DB; Vigo-Pelfrey C; Lieberburg I; Wurtman RJ; Hyman BT
Ann Neurol; 1995 Apr; 37(4):512-8. PubMed ID: 7717688
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
9. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.
Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC
Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon 4 allele distribution in alcoholic dementia and in Alzheimer's disease in Japan.
Muramatsu T; Higuchi S; Arai H; Sasaki H; Yamada K; Hayashida M; Trojanowski JQ
Ann Neurol; 1994 Nov; 36(5):797-9. PubMed ID: 7979227
[TBL] [Abstract][Full Text] [Related]
11. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.
Osuntokun BO; Sahota A; Ogunniyi AO; Gureje O; Baiyewu O; Adeyinka A; Oluwole SO; Komolafe O; Hall KS; Unverzagt FW
Ann Neurol; 1995 Sep; 38(3):463-5. PubMed ID: 7668835
[TBL] [Abstract][Full Text] [Related]
12. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
[TBL] [Abstract][Full Text] [Related]
13. Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia.
Matsushita S; Arai H; Muramatsu T; Makimoto K; Nakagawa T; Sasaki H; Higuchi S
Exp Neurol; 1997 Aug; 146(2):567-9. PubMed ID: 9270069
[TBL] [Abstract][Full Text] [Related]
14. Amyloid beta-peptide and the dementia of Parkinson's disease.
Jendroska K; Lees AJ; Poewe W; Daniel SE
Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090
[TBL] [Abstract][Full Text] [Related]
15. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.
Parsian A; Racette B; Goldsmith LJ; Perlmutter JS
Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377
[TBL] [Abstract][Full Text] [Related]
17. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy.
Nicoll JA; Burnett C; Love S; Graham DI; Dewar D; Ironside JW; Stewart J; Vinters HV
Ann Neurol; 1997 Jun; 41(6):716-21. PubMed ID: 9189032
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies.
Nalbantoglu J; Gilfix BM; Bertrand P; Robitaille Y; Gauthier S; Rosenblatt DS; Poirier J
Ann Neurol; 1994 Dec; 36(6):889-95. PubMed ID: 7998776
[TBL] [Abstract][Full Text] [Related]
19. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
Williams S; Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
[TBL] [Abstract][Full Text] [Related]
20. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
